Risk Reduction in Coronary Heart Disease

• Status: Completed
• Trial end date: 2019-12-01
• Target enrollment: 0
• Participant gender: All

Summary

Study hypothesis: Multifactorial risk reduction in coronary heart disease can reduce the risk of new coronary heart disease and death

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Sorlandet Hospital HF
• Collaborator: Oslo University Hospital
• Treatments: Adrenergic beta-Antagonists; Diuretics; Ezetimibe; Glimepiride; Insulin; Metformin; Vaccines

Criteria

Inclusion Criteria:

• acute myocardial infarction, CABG or PCI

Exclusion Criteria:

• Age < 18 and age > 80

• pregnant

• critical illness

• drug abuse